Clinical trials
Placebo clinical trials
Below are recruiting placebo clinical trials, each written for real people, not researchers. We’re tracking 5,240 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06714513RecruitingPhase 1
TB vaccine study in older adults aged 55 to 74
This study tests a new tuberculosis (TB) vaccine (ID93+GLA-SE) in healthy adults aged 55 to 74. It aims to see if the vaccine is safe and can help protect against TB, especially in people who may have latent (inactive) TB infection.
Gwangmyeong, Gyeonggi-doAges 55–74 - NCT06716203RecruitingPhase 3
Study of BGM0504 for type 2 diabetes not well controlled by diet and exercise
This trial tests a new medication called BGM0504 for people with type 2 diabetes that is not well managed with diet and exercise alone. It aims to see if the drug can help lower blood sugar levels.
Beijing, Beijing MunicipalityAges 18–75 - NCT06716151RecruitingPhase 1
HB0034 study for healthy Chinese adults
This trial tests a new medicine called HB0034 in healthy volunteers. It helps researchers understand how the drug works in the body before testing it in people with a medical condition.
Jinan, ShandongAges 18–45 - NCT06716281RecruitingPhase 3
Stem cell injection for knee osteoarthritis
This study tests a new stem cell treatment for knee osteoarthritis. It aims to see if injecting these cells into the knee can reduce pain and improve function compared to other treatments.
ShanghaiAges 40–80 - NCT06717698RecruitingPhase 2
Testing a new medicine for kidney damage in chronic kidney disease
This study tests different doses of an investigational medicine (NNC0519-0130) to see if it can reduce kidney damage in people with chronic kidney disease. It may be an option for you if you have kidney impairment and either have or don't have type 2 diabetes.
San Dimas, CaliforniaAges 18 years+ - NCT06717867RecruitingPhase 2
Long-term safety study of PEA for healthy adults
This trial is testing the long-term safety of a supplement called PEA in generally healthy adults. It aims to make sure the supplement is safe when taken over a longer period.
Brisbane, QueenslandAges 18 years+ - NCT06718426Recruiting
Testing Fertitonex for varicocele and infertility
This study tests if a medicine called Fertitonex can improve sperm quality in men who have varicocele (enlarged veins in the scrotum) and are having trouble getting their partner pregnant for the first time.
Shebin El-Kom, MenoufiaAges 18 years+ - NCT06718686RecruitingPhase 1/Phase 2
Rifaximin for Dementia
This study tests a new antibiotic (rifaximin) to see if it can help people with mild to moderate Alzheimer's or vascular dementia. You and a caregiver would come to the clinic for check-ups to monitor how you're doing.
Richmond, VirginiaAges 65 years+ - NCT06721013RecruitingPhase 1/Phase 2
Study of Pirtobrutinib for immune thrombocytopenia
This trial tests a new drug called pirtobrutinib for people with immune thrombocytopenia (ITP) who have not responded well to other treatments. The goal is to see if it can help raise your platelet count and reduce bleeding risk.
Los Angeles, CaliforniaAges 18 years+ - NCT06721949RecruitingPhase 2/Phase 3
Taurine for long COVID symptoms
This trial tests if taking taurine, a natural amino acid supplement, can help reduce lingering symptoms of COVID-19 that last for months. If you have had COVID-19 and still have symptoms like fatigue or brain fog for at least 2 months after 3 months from your infection, this study might be for you.
Edmonton, AlbertaAges 18 years+ - NCT06722534Recruiting
Celecoxib to prevent polyps from growing in Peutz-Jeghers Syndrome
This trial is testing if the medication celecoxib can stop or slow the growth of polyps in people with Peutz-Jeghers Syndrome (PJS). It may help reduce the need for surgery and lower the risk of complications.
Xi'an, ShaanxiAges 8 years+ - NCT06722586RecruitingPhase 4
Sirolimus alone for low platelet counts from antiphospholipid antibodies
This trial tests if sirolimus, a medicine that calms the immune system, can safely raise platelet counts in people with antiphospholipid antibodies and persistently low platelets. It may be an option if other treatments haven't worked or you want a simpler drug plan.
Changsha, HunanAges 18 years+ - NCT06723119Recruiting
Resveratrol supplement for exercise and recovery in men
This study tests whether a daily supplement called resveratrol (found in some foods) can help active men exercise better and recover faster. You'll take either resveratrol or a placebo, follow a diet, and complete fitness tests.
Orlando, FloridaAges 18–40 - NCT06723392RecruitingPhase 3
Treating bladder bacteria in pregnancy to prevent infections
This trial tests if a common antibiotic can safely treat bacteria in the urine of pregnant women who have no symptoms, to see if it prevents later infections. It focuses on women in low- and middle-income countries.
Dhaka, BangladeshAges 18–49 - NCT06723444Recruiting
Improving Memory in Portuguese Patients with Multiple Sclerosis
This study tests a new method to improve memory and learning in people with multiple sclerosis who have mild memory problems. You'll undergo memory training and assessments to see if it helps.
PortoAges 18–70 - NCT06727422RecruitingPhase 2
Rifaximin plus NAC for IBS with diarrhea
This trial tests whether a combination of two medications—rifaximin (a gut antibiotic) and NAC (a supplement that helps break down mucus)—can reduce belly pain and diarrhea in people with IBS whose symptoms are not well controlled. It may be an option if other treatments haven't worked well enough.
Los Angeles, CaliforniaAges 18 years+ - NCT06727604RecruitingPhase 2
Study of IMVT-1402 for Graves' disease not controlled by medication
This trial tests a new drug called IMVT-1402 for adults with Graves' disease whose thyroid is still overactive despite taking antithyroid medication. The goal is to see if the drug can safely help control thyroid hormone levels.
Phoenix, ArizonaAges 18–75 - NCT06727773RecruitingPhase 2
Memantine and exercise to protect thinking during chemo for breast cancer
This study tests whether a medicine called memantine combined with a structured exercise program can help protect your thinking and memory during chemotherapy for breast cancer. It may also help understand how these treatments work in the body.
Chapel Hill, North CarolinaAges 18 years+ - NCT06731335RecruitingPhase 2
Psilocybin for chronic nerve pain that hasn't improved with other treatments
This study tests whether psilocybin (a compound found in certain mushrooms) can help reduce chronic nerve pain that has not responded well to standard medications. You will receive study treatment plus psychotherapy to see if it improves your pain.
Toronto, OntarioAges 18–65 - NCT06731374RecruitingPhase 4
New pneumonia vaccine study for healthy adults 18–50
This study tests a new pneumococcal vaccine (PCV15) to see how well it protects against carrying the bacteria that can cause pneumonia. Healthy adults aged 18–50 who have not had a pneumococcal vaccine in the last 5 years may join.
Liverpool, North WestAges 18–50 - NCT06731647RecruitingPhase 2
Anti-inflammatory drugs for pleurodesis in pneumothorax
This trial tests whether using non-steroidal anti-inflammatory drugs (NSAIDs) during pleurodesis (a procedure to seal the lung lining) helps people with a collapsed lung (pneumothorax). It aims to see if these drugs can improve outcomes.
AmiensAges 18 years+ - NCT06731894RecruitingPhase 2
Cannabis for nerve pain after chemotherapy in breast and colon cancer survivors
This trial tests whether a cannabis-based product can reduce nerve damage (neuropathy) caused by chemotherapy in people who have finished treatment for breast or colon cancer. It focuses on survivors who still have pain, numbness, or tingling in their hands or feet.
Duarte, CaliforniaAges 18 years+ - NCT06732895RecruitingPhase 2
Weekly injection for teens with achondroplasia
This trial tests a weekly injection called navepegritide for adolescents aged 12-18 with achondroplasia (a common form of dwarfism). The goal is to see if it can safely improve growth. You must have a genetic confirmation of achondroplasia and a historical height measurement from the past 6 to 15 months.
MontrealAges 12–17 - NCT06735053Recruiting
Virtual reality physiotherapy for multiple sclerosis patients
This trial tests whether virtual reality exercises can help people with advanced multiple sclerosis improve their movement and walking. You may qualify if you need two walking aids and your MS has been stable for the last six months.
Móstoles, MadridAges 18–70
Hear when a new Placebo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo?
- Yes. Clin2 currently lists 5,240 recruiting placebo studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.